ArticleQuantitative imaging in medicine and surgery2026
Epicardial adipose tissue density, myocardial fibrosis, and heart failure with preserved ejection fraction in postmenopausal women: a mediation analysis.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Heart failure with preserved ejection fraction (HFpEF) predominantly affects postmenopausal women, but its underlying mechanisms remain unclear. Epicardial adipose tissue (EAT), a metabolically active fat depot adjacent to the myocardium, has been implicated in HFpEF. This study aimed to evaluate the associations of EAT volume and density with HFpEF in postmenopausal women and to determine whether myocardial fibrosis mediates this relationship. Methods: In this retrospective cross-sectional study, we included 70 postmenopausal women with HFpEF and 70 age-matched controls (±3 years) who underwent cardiac computed tomography (CT). EAT volume and density were quantified from coronary artery calcium scoring images. Myocardial extracellular volume (ECV), derived from dual-energy CT, was used to quantify myocardial fibrosis. Multivariable regression analyses and mediation analyses were performed to evaluate the associations between EAT characteristics, ECV, and HFpEF. Results: EAT volume index, density, and ECV were significantly higher in the HFpEF group than in controls (all P<0.05). After adjustment for cardiovascular risk factors and comorbidities, higher EAT density [per 1-Hounsfield unit (HU) increase; odds ratio (OR) =1.209; 95% confidence interval (CI): 1.073-1.362; P=0.002] and ECV (per 1% increase; OR =1.306; 95% CI: 1.104-1.510; P=0.001) remained independently associated with HFpEF. ECV mediated 47.7% of the relation between EAT density and HFpEF (effect =0.188; 95% CI: 0.094-0.296; P<0.05). EAT density was independently associated with ECV in the postmenopausal population (β =0.39, P<0.001). Conclusions: EAT density is more strongly and independently associated with HFpEF in postmenopausal women than EAT volume. Myocardial fibrosis, measured as ECV, partially mediated the association between EAT density and HFpEF, supporting the concept of an EAT-myocardial fibrotic axis in the pathophysiology of HFpEF in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.